West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nineteen analysts that are covering the firm, Ratings reports. Eight research ...

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...

KBC Group NV grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 3,862.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange ...

While there is a very civilized debate to be had over reboots, literary appropriations and innovative casting, “Watson” does seem like a mischievous middle finger to anyone with hidebound ...

Search for a state or federal candidate to see the donors and industries that support them. Ballot measures allow voters to vote directly on a law or policy change. Explore the ballot measures ...

Actor Morris Chestnut stars as Dr. John Watson in CBS' new series "Watson," solving medical mysteries while continuing Sherlock Holmes' legacy after his partner's death. The show combines hospital ...

“The canon is always very much with us. The life that Watson had with Sherlock is not done with him,” executive producer Craig Sweeny promises of the new CBS drama starring Morris Chestnut as ...